Marc Zimmerman
Hematology & Oncology · Pomona, NYNPI 1568543742
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.9% of the total across 117 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 9.2% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for hematology & oncology clinicians in NY, where the typical reported total is $1,337.
Across 117 payments — averaging $17.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$183
- E.r. Squibb & Sons, L.L.C.$170
- Amgen$168
- Novartis$159
- Merck$151
- Octapharma USA, Inc.$103
- plus $1K from 29 others
What the payments were for
- Food & beverage$1,88895%
- Education$1015%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 14 | $183 |
| E.r. Squibb & Sons, L.L.C. | 12 | $170 |
| Amgen | 10 | $168 |
| Novartis | 9 | $159 |
| Merck | 13 | $151 |
| Octapharma USA, Inc. | 1 | $103 |
| Eisai Inc. | 5 | $93 |
| Johnson & Johnson(2 entities) | 5 | $86 |
| Genentech USA, Inc. | 5 | $85 |
| AstraZeneca | 5 | $81 |
| Novocure Inc. | 1 | $81 |
| Tersera Therapeutics LLC | 2 | $55 |
| Boehringer Ingelheim | 4 | $50 |
| Ipsen Biopharmaceuticals, Inc | 2 | $49 |
| AMAG Pharmaceuticals, Inc. | 2 | $44 |
| Clovis Oncology, Inc. | 3 | $35 |
| Shire North American Group Inc | 2 | $35 |
| Gilead | 2 | $32 |
| Bristol Myers Squibb | 2 | $30 |
| Incyte Corporation | 1 | $27 |
| Agios Pharmaceuticals, Inc. | 2 | $26 |
| Astellas Pharma US Inc | 2 | $26 |
| Bayer | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Taiho Oncology, Inc. | 1 | $21 |
| Tolmar Pharmaceuticals, Inc. | 1 | $18 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $18 |
| Medtronic | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $13 |
| Tesaro, Inc. | 1 | $13 |
| Seagen Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUWIQ$103
How this compares
$1,989 in reported general payments places this provider in the 50th percentile of 967 hematology & oncology providers in New York.
Other hematology & oncology in Pomona
- Michael SchusterNew York$1.6M
- Charles SawyersNew York$1.6M
- Manuel Hidalgo-MedinaNew York$1.4M
- Francis ArenaLake Success$1M
- Sanjeev JainEast Patchogue$971K
- Ross LevineNew York$968K
- Perry CookBrooklyn$803K
- Mihir RavalAlbany$767K
- Joshua SabariNew York$761K
- Gail RobozNew York$738K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.